The preclinical development of biosimilars: introduction von Bui, Lynne A.

Volltext

Developing Clinical Trials for Biosimilars von Bui, Lynne A, Taylor, Carrie

Volltext

Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor von Verstovsek, Srdan, Tam, Constantine S, Wadleigh, Martha, Sokol, Lubomir, Smith, Catherine C, Bui, Lynne A, Song, Chunyan, Clary, Douglas O, Olszynski, Patrycja, Cortes, Jorge, Kantarjian, Hagop, Shah, Neil P

Volltext

Key considerations in the preclinical development of biosimilars von Bui, Lynne A., Hurst, Susan, Finch, Gregory L., Ingram, Beverly, Jacobs, Ira A., Kirchhoff, Carol F., Ng, Chee-Keng, Ryan, Anne M.

Volltext

A phase I pharmacokinetic and safety study of Paclitaxel Injection Concentrate for Nano-dispersion (PICN) alone and in combination with carboplatin in patients with advanced solid... von Ma, Wen Wee, Zhu, Mojun, Lam, Elaine T., Diamond, Jennifer R., Dy, Grace K., Fisher, George A., Goff, Laura Williams, Alberts, Steven, Bui, Lynne A., Sanghal, Akhil, Kothekar, Mudgal, Khopade, Ajay, Chimote, Geetanjali, Faulkner, Robert, Eckhardt, S. Gail, Adjei, Alex A., Jimeno, Antonio

Volltext

774 An induced pluripotent stem cell (iPSC) vaccine is highly immunogenic and reduces lung metastases in a mouse model of melanoma von Hundt, Matthias, Bove, Peter, Hernandez, Ivan, Li, Michelle, Beviglia, Lucia, Kundu, Pratima, Ndoye, Babacar, Kooreman, Nigel, Wolpe, Stephen, Bui, Lynne

Volltext

775 An induced pluripotent stem cell (iPSC) vaccine decreases tumor growth and improves survival in a therapeutic mouse model of colon cancer von Hundt, Matthias, Li, Michelle, Huang, Hui, Obejero-Paz, Carlos, Bove, Peter, Hernandez, Ivan, Kundu, Pratima, Kooreman, Nigel, Wolpe, Stephen, Bui, Lynne

Volltext

414 Efficacy and immunogenicity of induced pluripotent stem cell (iPSC) vaccine is independent of iPSC viability in a prophylactic mouse model of breast cancer von Hundt, Matthias, Inamdar, Sahil, Huang, Hui, Dai, Hong, Obejero-Paz, Carlos A, Kundu, Pratima, Hernandez, Ivan, Kooreman, Nigel G, Wolpe, Stephen D, Bui, Lynne A

Volltext

415 Both allogeneic and syngeneic induced pluripotent stem cell (iPSC) vaccines decrease tumor growth and improve survival in a prophylactic mouse model of breast cancer von Inamdar, Sahil, Obejero-Paz, Carlos A, Kundu, Pratima, Foust, Skylar R, Hernandez, Ivan, Kooreman, Nigel G, Wolpe, Stephen D, Bui, Lynne A, Hundt, Matthias

Volltext

GABAergic organization of the auditory cortex in the mustached bat (Pteronotus p. parnellii) von Winer, Jeffery A., Bui, Lynne A., Hong, Jane H., Prieto, Jorge J., Larue, David T.

Volltext

Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells von RIBAS, A, BUTTERFIELD, L. H, GLASPY, J. A, ECONOMOU, J. S, MCBRIDE, W. H, JILANI, S. M, BUI, L. A, VOLLMER, C. M, LAU, R, DISSETTE, V. B, HU, B, CHEN, A. Y

Volltext

Generation of Melanoma-Specific Cytotoxic T Lymphocytes by Dendritic Cells Transduced with a MART-1 Adenovirus von Butterfield, Lisa H, Jilani, Syed M, Chakraborty, Nitya G, Bui, Lynne A, Ribas, Antoni, Dissette, Vivian Beck, Lau, Roy, Gamradt, Seth C, Glaspy, John A, McBride, William H, Mukherji, Bijay, Economou, James S

Volltext

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (IN... von Wu, Yi-Long, Cheng, Ying, Zhou, Jianying, Lu, Shun, Zhang, Yiping, Zhao, Jun, Kim, Dong-Wan, Soo, Ross Andrew, Kim, Sang-We, Pan, Hongming, Chen, Yuh-Min, Chian, Chih-Feng, Liu, Xiaoqing, Tan, Daniel Shao Weng, Bruns, Rolf, Straub, Josef, Johne, Andreas, Scheele, Jurgen, Park, Keunchil, Yang, James Chih-Hsin

Volltext

Phase II trial of BPM31510-IV plus gemcitabine in advanced pancreatic ductal adenocarcinomas (PDAC) von Kundranda, Madappa N., Propper, David, Ritch, Paul S., Strauss, James, Hidalgo, Manuel, Gillmore, Roopinder, Sarangarajan, Rangaprasad, Narain, Niven R., Kiebish, Michael A., Rodrigues, Leonardo O, Granger, Elder, Ramanathan, Ramesh, Alistar, Angela Tatiana, Bui, Lynne A., Chawla, Sant P., Niewiarowska, Anna A.

Volltext

nab -Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC von Langer, Corey J, Kim, Edward S, Anderson, Eric C, Jotte, Robert M, Modiano, Manuel, Haggstrom, Daniel E, Socoteanu, Matei P, Smith, David A, Dakhil, Christopher, Konduri, Kartik, Berry, Tymara, Ong, Teng J, Sanford, Alexandra, Amiri, Katayoun, Goldman, Jonathan W, Weiss, Jared

Volltext

A phase I and pharmacokinetic study of a weekly dosing schedule of paclitaxel injection concentrate for nano-dispersion (PICN) in patients with advanced solid tumors von Ma, Wen Wee, Diamond, Jennifer Robinson, Dy, Grace K., Messersmith, Wells A., Zhao, Yujie, Bui, Lynne A., Fetterly, Gerald J., Harning, Ronald, Wolfe, Henry Raphael, Pencheva, Pepi, Bhowmik, Shravanti, Divekar, Ganesh, Lakkad, Narendra B., Khopade, Ajay J., DiRaddo, Ann Marie, Eckhardt, S. Gail, Adjei, Alex A., Jimeno, Antonio

Volltext

GABAergic organization of the auditory cortex in the mustached bat (Pteronotus p. parnellii): Central Auditory Pathways - A Memorial Tribute to Jeffery A. Winer von WINER, Jeffery A, BUI, Lynne A, HONG, Jane H, PRIETO, Jorge J, LARGE, David T

Volltext

A pharmacokinetic and dose-escalating study of paclitaxel injection concentrate for nano-dispersion (PICN) alone and with carboplatin in patients with advanced solid tumors von Ma, Wen Wee, Lam, Elaine Tat, Dy, Grace K., Diamond, Jennifer Robinson, Zhao, Yujie, Bui, Lynne A., Fetterly, Gerald J., Abramowitz, Wattanaporn, Harning, Ronald, Pencheva, Pepi, Bhowmik, Shravanti, Divekar, Ganesh Harishchandra, DiRaddo, Ann Marie, Eckhardt, S. Gail, Adjei, Alex A., Jimeno, Antonio

Volltext

Abstract 5588: A phase I, open label, dose escalation study of an oral mammalian target of rapamycin inhibitor INK128 administered once daily in patients with advanced malignancies von Infante, Jeffrey R., Tabernero, Josep, Burris, Howard A., Macarulla, Teresa, Martin, Michael, Liu, Yi, Jessen, Katti, Koczon, Ethel, Rommel, Christian, Klein, Pam M., Berk, Greg I., Bui, Lynne A., Gordon, Michael S.

Volltext

Abstract CT-02: A phase I, open label, dose escalation study of oral mammalian target of rapamycin inhibitor INK128 administered by intermittent dosing regimens in patients with ad... von Tabernero, Josep, Cervantes, Andres, Gordon, Michael S., Chiorean, Elena G., Burris, Howard A., Macarulla, Teresa, Perez-Fidalgo, Alejandro, Martin, Michael, Jessen, Katti, Liu, Yi, Le, Trinh, Rommel, Christian, Berk, Greg I., Bui, Lynne A., Infante, Jeffrey R.

Volltext